Learn more

METACINE INC

Overview
  • Total Patents
    21
  • GoodIP Patent Rank
    92,894
  • Filing trend
    0.0%
About

METACINE INC has a total of 21 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2012. It filed its patents most often in Republic of Korea, United States and China. Its main competitors in its focus markets pharmaceuticals, foods and drinks and medical technology are TRANSCU LTD, ACCELERATED CARE PLUS CORP and TRANSPORT PHARMACEUTICALS INC.

Patent filings per year

Chart showing METACINE INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Park Bae Keun 20
#2 Park Sung Hoon 3
#3 Park Ju-Young 2
#4 Yoon Sung-Hwa 2
#5 Yoon Sung Hwa 1
#6 Jeong Chang Hyun 1
#7 Park Ju Young 1
#8 Park Bae-Keun 1
#9 Rhew Tae Hyong 1

Latest patents

Publication Filing date Title
US2020054891A1 Rhinitis photo therapeutic device with a nasal probe using low-level laser based on diffusing light technology
KR20200068969A Multifunctional aesthetic equipment
KR20200019545A Rhinitis photo therapeutic device with a nasal probe using low-level laser based on diffusing light technology
KR20200025072A Composition for skin whitening, or preventing or improving skin hyper-pigmented diseases comprising extract of Paulownia coreana
KR20190026407A Pharmaceutical composition for inhibiting cancer or bone metastases, or preventing or treating osseous metabolic disease
KR20190026409A Pharmaceutical composition for inhibiting cancer or bone metastases, or preventing or treating osseous metabolic disease comprising an extract of Isodon species
KR20190026410A Pharmaceutical composition for preventing of treating osseous metabolic disease comprising inflexinol
KR20170101688A Method for screening cancer or cancer metastasis therapeutic agent using FSTL1 protein
KR20170060995A Pharmaceutical composition containing a FSTL1 protein for the prevention and treatment of cancer
KR20170059076A Pharmaceutical composition containing a FSTL1 protein for the Suppression of cancer metastasis
KR20170058104A Pharmaceutical composition containing a FSTL1 protein for the prevention and treatment of osseous metabolic diseases
KR20150098701A Apparatus for skin management of a face
US8623845B1 Pharmaceutical composition for preventing or treating Diabetes mellitus comprising bisphophonates
KR101191733B1 New compounds for inhibiting differentiation of osteoclast and pharmaceutical composition comprising thereof